The Art of the Evergreening: A Deep Dive into Drug Life Cycle Management Tactics and How to Challenge Them
In pharmaceuticals no event looms larger or casts a longer shadow than the patent cliff. It is a moment of […]
Bayerische Motoren Werke Aktiengesellschaft v. Onesta IP, LLC
Litigation Summary and Analysis: Bayerische Motoren Werke Aktiengesellschaft v. Onesta IP, LLC (26-1338) Executive Summary Bayerische Motoren Werke Aktiengesellschaft (BMW)
Bayerische Motoren Werke Aktiengesellschaft v. Onesta IP, LLC Read Post »
The Orphan Drug Paradox: A Strategic Playbook for Generic Entry in Rare Disease Markets
The global rare disease treatment market, a sector born from legislative incentives to address profound unmet needs, is on an
The Orphan Drug Paradox: A Strategic Playbook for Generic Entry in Rare Disease Markets Read Post »
The French Gambit: Can a Resurgent Life Sciences Ecosystem Spark the Next Medical Revolution?
Executive Summary: The Verdict on France’s Medical Revolution The global pharmaceutical landscape stands at the precipice of a new era,
Global Exclusivity Divergence: Hatch-Waxman PTE Versus European SPC Extensions
1. The Economics of Time in Biopharma Biopharmaceutical asset valuation rests on a single, volatile variable: the duration of market
Global Exclusivity Divergence: Hatch-Waxman PTE Versus European SPC Extensions Read Post »
IPR vs. Hatch-Waxman: A C-Suite Guide to Choosing the Right Venue for Your Pharmaceutical Patent Challenge
In the world of pharmaceuticals a patent represents the culmination of a decade or more of painstaking research, countless failed
Decoding Durability: A New Era of AI-Powered Drug Patent Strength and Invalidity Risk Assessment
A drug patent is more than a legal document; it is the financial bedrock upon which entire companies are built.
Patenting the Sum of the Parts: A Comprehensive Analysis of Drug Combination Intellectual Property Strategy
Section 1: The Fundamental Question of Patentability for Drug Combinations 1.1 Introduction: Beyond a Simple “Yes” – The Strategic Imperative
Patenting New Uses for Existing Drugs: A Legal and Strategic Analysis of Drug Repurposing
Section 1: Introduction: The Value and Paradox of Second Acts in Pharmacology The Rise of Drug Repurposing Drug repurposing, also
